Navigation Links
AquaMax 1536 Dispenser

ProductsAquaMax 1536 Dispenser
Company Molecular Devices Corporation
Item AquaMax 1536 Dispenser
Features Inquire
Description Automatic dispenser for low volumes. Dispenses volumes down to 0.5ul for 384 and 1536 -well format. Fast throughput of less than 30 seconds per plate significantly improves productivity. The dispenser features an intuitive user interface that provides one-button dispensing. It can be used to dispense liquids and suspensions, beads, or cells, with high precision (typically <10%CV @ 1 ul for 384 and 1536 format). User can switch from 96/384 dispense head to 1536 dispense head with ease.
Info Molecular Devices Corporation
Customer Service: (800) 635-5577
Web site: http://www.moleculardevices.com/

Related medicine products :

1. AquaMax DW4
2. AquaMax 96/384 Dispenser
3. Wall-Mount Glove Dispenser, Single
4. Wall-Mount Glove Dispenser, Triple
5. Benchtop Glove Dispenser
6. Fill, Microplate Reagent Dispenser
7. FlexDrop III Precision Reagent Dispenser
8. FlexDrop IV Precision Reagent Dispenser
9. miniGene Line Dispenser
10. 402 Dilutor-Dispenser, single-syringe, 220v (French version)
11. WellMate Microplate Fluid Dispenser
... Focus from Thermo Labsystems was designed specifically ... Advanced features such as the new fast ... on microvolumes help to define this as ... The new interchangeable handle plate offers a ...
... range from 2ul to 5000ul. Fills and ... prevents inadvertent volume change. Novel hand grip ... is autoclavable at 121C(250F). To prevent corrosion ... for one-handed operation. Auto or Normal trigger ...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... Product features: Eppendorf "pipette/tip" system ensures ...
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 0.5-10 microliter range....
Medicine Products:
(Date:12/19/2014)... 2014 If you have ever been ... you probably wished you had an arsenal of treatments ... fibrosis, and other breathing disorders. Currently, the only proven ... triggers, but other common treatments do exist. At ... San Antonio, TX, 34 asthma educators responded to a ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 This is ... of the global Gliquidone industry with a focus on ... the market status of the Gliquidone manufacturers and is ... and individuals interested in the industry. , Firstly, the ... its definition, applications and manufacturing technology. Then, the report ...
(Date:12/19/2014)... 2014 (HealthDay News) -- A new study suggests a ... severe hot flashes and night sweats -- and higher ... flashes are common during menopause, affecting about 60 percent ... women after menopause, since they then face a higher ... suggest women who exhibit moderate or severe menopausal symptoms ...
(Date:12/19/2014)... Traveling through the same U.S. airport gate, one infected ... a four-hour time span, illustrating just how easily the ... exposures in this report were not prolonged and occurred ... the fact that measles is highly contagious," wrote a ... at the U.S. Centers for Disease Control and Prevention. ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Dr. Myo Nwe ... Weight Loss Diet of the Future” and co-founder of the ... her book, Dr. Nwe takes a broad look at the ... hold up under scientific scrutiny. On film and in television ... emphasized mostly toward the social aspects and played for basic ...
Breaking Medicine News(10 mins):Health News:Harmonica Techs, Inventors of the Pulmonica®, Unveil New Findings on Complementary Treatments for Asthma 2Health News:Harmonica Techs, Inventors of the Pulmonica®, Unveil New Findings on Complementary Treatments for Asthma 3Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 2Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 3Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 4Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 5Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 6Health News:Severe Hot Flashes During Menopause May Raise Hip Fracture Risk Later: Study 2Health News:Arriving Now at Gate 42: Measles 2Health News:Arriving Now at Gate 42: Measles 3Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2
... at Capitol to meet with legislators LANSING, Mich., May ... childhood investment supporters are expected at the Capitol Thursday, ... our youngest citizens is critical to Michigan,s economic future.It ... began in 2007."This issue is more important than ever ...
... announced today that it is making a $10,000 donation ... in the Santa Barbara area who have been impacted by ... In addition, Anthem announced today several additional actions it is ... Anthem Blue Cross members may have left ...
... May 8 Bertalan Mesko, medical blogger and health ... collections featuring medical and scientific videos and animations. ... from the best quality. Some of the sites are ... reliable videos focusing on health issues, while others were ...
... more likely to experience complications, study finds , , FRIDAY, ... likely than any other racial group to suffer serious ... procedures, but the reasons for these worse outcomes aren,t ... included 1,410 patients, average age 57, who had a ...
... May 8 The majority of uninsured American families ... an employer cannot afford to buy health insurance, according ... Research and Quality.Some experts have suggested that because 23.8 ... have access to employer-based health insurance have incomes above ...
... Free Student Memberships Now Available on Online Community ... Medical Device TechnologiesFERNANDINA BEACH, Fla., May 8 ... just a few short weeks since launch, e-Zassi.com ... medical device industry participants involved in the discovery, ...
Cached Medicine News:Health News:Early Childhood Funding is Focus of Star Power Event 2Health News:Anthem Blue Cross to Support Members and Communities Impacted by Santa Barbara Fires 2Health News:Racial Disparity Seen in Angioplasty Outcomes 2Health News:New Study Finds Fewer Families Can Afford Health Insurance 2Health News:New Advanced Search and Matching Function Drives e-Zassi.com's Enhanced Functionality 2
(Date:12/17/2014)... December 17, 2014 , ... than a hub of information concerning the biopharmaceutical Group,s national ... A further addition to the recently launched institutional website that ... now been enriched by a new chapter in the fascinating ... A richly detailed and panoramic hub on the world of ...
(Date:12/17/2014)... , Dec. 17, 2014  RXi Pharmaceuticals ... company focused on discovering, developing and commercializing innovative ... technologies, today announced completion of enrollment in its first ... the 3-month observations confirmed the 1-month findings that ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:12/15/2014)... LONDON , December 15, 2014 /PRNewswire/ ... Am 19. und 20. Februar ... das Aegate SAFE MEDICINE ECOSYSTEM PARTNER PROGRAMM ... zu besuchen. Diese Tagung ... Gemeinschaft die Möglichkeit geben, die neue profitablen ...
Breaking Medicine Technology:Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2